1913
DOI: 10.1007/bf02218315
|View full text |Cite
|
Sign up to set email alerts
|

Zur Histogenese und Histologie des Krebses

Abstract: Im folgenden mSchte ich mir, vielfach angeregt durch das neueste Werk Ribbertsl), einige Bemerkungea hinsichtlich der Histogenese des Krebses, des Polymorphismus der Krebszellen, der Klassifikation der Krebse iiberhaupt, der Benennung, des Vorkommens und Entstehens der Basalzellenkrebse im besonderen erlauben und zugleich aueh einige, auf die Morphologie der Krebse beziigliche Beobachtungen mitteilen.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1925
1925
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In 2000, Kaya et al examined two cases of MNTI and found that adjuvant therapy such as chemotherapy and radiation should be reserved for cases where resection with clear margins is impossible (Heba et al, 2008). Sailukar in 2007 administered a regime of neoadjuvant chemotherapy consisting of vincristine, cyclophosphamide and dactinomycin for a three-month-old child with MNTI and achieved 10% regression in the mass in two weeks showing a poor response to the treatment (Krompecher, 1978). Radiotherapy and combination chemotherapy including vinblastine, ifosphamide, etoposide, cyclophosphamide, doxorubicin and dactinomycin has been advocated for inoperable recurrences or margin positive resections (Sailukar et al, 2007).…”
Section: Discussionmentioning
confidence: 98%
“…In 2000, Kaya et al examined two cases of MNTI and found that adjuvant therapy such as chemotherapy and radiation should be reserved for cases where resection with clear margins is impossible (Heba et al, 2008). Sailukar in 2007 administered a regime of neoadjuvant chemotherapy consisting of vincristine, cyclophosphamide and dactinomycin for a three-month-old child with MNTI and achieved 10% regression in the mass in two weeks showing a poor response to the treatment (Krompecher, 1978). Radiotherapy and combination chemotherapy including vinblastine, ifosphamide, etoposide, cyclophosphamide, doxorubicin and dactinomycin has been advocated for inoperable recurrences or margin positive resections (Sailukar et al, 2007).…”
Section: Discussionmentioning
confidence: 98%
“…Melanotic neuroectodermal tumor of infancy (MNTI) is considered a rare and rapid-growing tumor. This entity of tumor was first described by Krompecher [1] in 1918. Since then, many synonyms were mentioned and published in various medical fields such as congenital melanocarcinoma, retinal anlage tumor, pigmented congenital epulis, and melanotic progonoma [2].…”
Section: Introductionmentioning
confidence: 99%